The company is betting that the alternative cytotoxic payload in its ADC can overcome resistance in patients who relapse on Enhertu.

Opinion: Legal scholar John Shu says a ban or restriction on direct-to-consumer drug advertisements would be illogical and ...

Dr. Adedoyin Dosunmu-Ogunbi, the hospital’s Medical Director, reiterated the central role of values in the hospital’s success ...